Dapiprazole
Suppliers
Names
[ CAS No. ]:
72822-12-9
[ Name ]:
Dapiprazole
[Synonym ]:
Rev-Eyes
1,2,4-Triazolo[4,3-a]pyridine, 5,6,7,8-tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-
3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine
5,6,7,8-Tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-1,2,4-triazolo[4,3-a]pyridine
Dapiprazole
Dapiprazol [German]
Dapirazol
Glamidolo
3-{2-[4-(2-Methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine
3-[2-(4-o-tolyl-piperazin-1-yl)-ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine
3-{2-[4-(2-Methylphenyl)-1-piperazinyl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine
5,6,7,8-Tetrahydro-3-[2-(4-o-tolyl-1-piperazinyl)ethyl]-s-triazolo[4,3-a]pyridine
5,6,7,8-tetrahydro-3-[2-(4-o-tolyl-1-piperazin)ethyl]-1,2,4-triazolo[4,3-a]pyridine
Reversil
Dapiprazole [INN]
Dapiprazol
dapiprazolum
Dapirazolum
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
538.9±60.0 °C at 760 mmHg
[ Molecular Formula ]:
C19H27N5
[ Molecular Weight ]:
325.451
[ Flash Point ]:
279.7±32.9 °C
[ Exact Mass ]:
325.226654
[ PSA ]:
37.19000
[ LogP ]:
2.44
[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C
[ Index of Refraction ]:
1.658
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- XZ5625000
- CHEMICAL NAME :
- s-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)et hyl)-, hydrochloride
- CAS REGISTRY NUMBER :
- 72822-12-9
- LAST UPDATED :
- 199009
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C19-H27-N5.Cl-H
- MOLECULAR WEIGHT :
- 361.97
- WISWESSER LINE NOTATION :
- T56 AN CNN&TJ B2- AT6N DNTJ DR B1 &GH
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 260 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - miosis (pupillary constriction) Behavioral - changes in motor activity (specific assay) Behavioral - ataxia
- REFERENCE :
- ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 32,668,1982